2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for GENENTECH INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Payment policies for prescription drugs

LobbyistCovered position, as disclosed
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues concerning clinical trials. Implementation of Patient Protection and Affordable Care Act. Congressional oversight issues. Reauthorization of the Prescription Drug User Fee Act. (FDA Safety and Innovation Act (S.3187))

LobbyistCovered position, as disclosed
REBECCA ANDERSON New White House Office of Legislative Affairs
SUSAN HIRSCHMANN New COS, Rep. Van Hilleary and Majority Whip
KARINA LYNCH —
ROBERT J MARTINEZ New —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th)

Taxation/Internal Revenue Code TAX

General tax issues and tax extenders

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
KARINA LYNCH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.